PREMIER HEALTH OF AMERICA IN (PHA.CA) Stock Fundamental Analysis
Canada - TSX Venture Exchange - TSX-V:PHA - CA74052G1063 - Common Stock
0.025 CAD
0 (0%)
PHA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 14 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of PHA have multiple concerns. PHA has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- In the past year PHA has reported negative net income.
- PHA had a positive operating cash flow in the past year.
- The reported net income has been mixed in the past 5 years: PHA reported negative net income in multiple years.
- PHA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of -20.74%, PHA is doing worse than 73.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -20.74% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-6.71%
ROA(5y)-3.2%
ROE(3y)-105.76%
ROE(5y)-61.59%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Gross Margin, with a value of 16.12%, PHA is doing worse than 73.33% of the companies in the same industry.
- PHA's Gross Margin has declined in the last couple of years.
- The Profit Margin and Operating Margin are not available for PHA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 16.12% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.25%
GM growth 5Y-4.32%
2. Health
2.1 Basic Checks
- PHA does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for PHA has been increased compared to 1 year ago.
- PHA has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, PHA has a worse debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of 0.54, we must say that PHA is in the distress zone and has some risk of bankruptcy.
- PHA has a Altman-Z score of 0.54. This is in the lower half of the industry: PHA underperforms 73.33% of its industry peers.
- The Debt to FCF ratio of PHA is 5.80, which is a neutral value as it means it would take PHA, 5.80 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of PHA (5.80) is better than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 5.8 | ||
| Altman-Z | 0.54 |
ROIC/WACCN/A
WACC9.92%
2.3 Liquidity
- A Current Ratio of 0.44 indicates that PHA may have some problems paying its short term obligations.
- PHA has a Current ratio of 0.44. This is in the lower half of the industry: PHA underperforms 66.67% of its industry peers.
- A Quick Ratio of 0.44 indicates that PHA may have some problems paying its short term obligations.
- With a Quick ratio value of 0.44, PHA is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.44 | ||
| Quick Ratio | 0.44 |
3. Growth
3.1 Past
- PHA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.76%.
- The Revenue for PHA has decreased by -22.61% in the past year. This is quite bad
- Measured over the past years, PHA shows a very strong growth in Revenue. The Revenue has been growing by 68.58% on average per year.
EPS 1Y (TTM)7.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.24%
Revenue 1Y (TTM)-22.61%
Revenue growth 3Y33.41%
Revenue growth 5Y68.58%
Sales Q2Q%-47.18%
3.2 Future
- PHA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.79% yearly.
- The Revenue is expected to decrease by -5.61% on average over the next years.
EPS Next Y40.21%
EPS Next 2Y18.19%
EPS Next 3Y11.79%
EPS Next 5YN/A
Revenue Next Year-20.72%
Revenue Next 2Y-10.85%
Revenue Next 3Y-5.61%
Revenue Next 5YN/A
3.3 Evolution
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for PHA. In the last year negative earnings were reported.
- Also next year PHA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- PHA's Enterprise Value to EBITDA ratio is in line with the industry average.
- PHA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PHA is cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 0.18 | ||
| EV/EBITDA | 199.56 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.19%
EPS Next 3Y11.79%
5. Dividend
5.1 Amount
- No dividends for PHA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
PREMIER HEALTH OF AMERICA IN / PHA.CA FAQ
What is the fundamental rating for PHA stock?
ChartMill assigns a fundamental rating of 2 / 10 to PHA.CA.
What is the valuation status of PREMIER HEALTH OF AMERICA IN (PHA.CA) stock?
ChartMill assigns a valuation rating of 2 / 10 to PREMIER HEALTH OF AMERICA IN (PHA.CA). This can be considered as Overvalued.
How profitable is PREMIER HEALTH OF AMERICA IN (PHA.CA) stock?
PREMIER HEALTH OF AMERICA IN (PHA.CA) has a profitability rating of 1 / 10.